Lu Shen
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- DNA Repair Mechanisms 4
- Oncology 20
- Drug Transport and Resistance Mechanisms 7
- Cancer-related Molecular Pathways 5
- Co-authors
- Shengying Qin (37 shared papers)Lin He (23 shared papers)Mo Li (18 shared papers)Cong Huai (12 shared papers)Na Zhang (5 shared papers)Mingzhe Zhao (4 shared papers)Xianglong Zhao (3 shared papers)Bixuan Jiang (2 shared papers)
- Journals
- PLoS ONE (8 papers)Genomics (3 papers)Toxicology Letters (3 papers)Translational Psychiatry (3 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Lu Shen
104 papers receiving 2.3k citations
Lu Shen's Hit Papers
Peers
Comparison fields: 5 of 141
- Pharmacology 376
- Cancer Research 309
- Molecular Biology 893
- Oncology 296
- Endocrinology, Diabetes and Metabolism 156
Countries citing papers authored by Lu Shen
This map shows the geographic impact of Lu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Shen more than expected).
Fields of papers citing papers by Lu Shen
This network shows the impact of papers produced by Lu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Shen. The network helps show where Lu Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytochrome P450 Enzymes and Drug Metabolism in Humans Hit paper breakdown → | 2021 | 604 |
| 2 | 2014 | 161 | |
| 3 | 2012 | 118 | |
| 4 | 1968 | 96 | |
| 5 | 2020 | 89 | |
| 6 | 2008 | 70 | |
| 7 | 2012 | 45 | |
| 8 | 2018 | 43 | |
| 9 | 2012 | 42 | |
| 10 | 2015 | 40 | |
| 11 | 2020 | 38 | |
| 12 | 2012 | 37 | |
| 13 | 2015 | 36 | |
| 14 | 2015 | 34 | |
| 15 | 2013 | 32 | |
| 16 | 2015 | 31 | |
| 17 | 2017 | 28 | |
| 18 | 2021 | 27 | |
| 19 | 2011 | 27 | |
| 20 | 2012 | 26 |
About Lu Shen
Lu Shen is a scholar working on Molecular Biology, Oncology, Genetics, Pharmacology and Cellular and Molecular Neuroscience, having authored 109 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Lung Cancer Treatments and Mutations (6 papers), Genetic Associations and Epidemiology (5 papers), Cancer-related Molecular Pathways (5 papers), Schizophrenia research and treatment (5 papers), Genetic Neurodegenerative Diseases (5 papers) and DNA Repair Mechanisms (4 papers). The work is most often cited by research in Pharmacology (376 citations), Cancer Research (309 citations), Molecular Biology (893 citations), Oncology (296 citations) and Endocrinology, Diabetes and Metabolism (156 citations). Lu Shen has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Shengying Qin, Lin He, Mo Li, Cong Huai, Na Zhang, Mingzhe Zhao, Xianglong Zhao, Bixuan Jiang, Yingtian Zhang and Jingsong Ma. Their work appears in journals such as PLoS ONE, Genomics, Toxicology Letters, Translational Psychiatry and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.